Cargando…
Transcription Factor Activity Inference in Systemic Lupus Erythematosus
Background: Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease with diverse clinical manifestations. Although most of the SLE-associated loci are located in regulatory regions, there is a lack of global information about transcription factor (TFs) activities, the mode of regulation...
Autores principales: | Lopez-Dominguez, Raul, Toro-Dominguez, Daniel, Martorell-Marugan, Jordi, Garcia-Moreno, Adrian, Holland, Christian H., Saez-Rodriguez, Julio, Goldman, Daniel, Petri, Michelle A., Alarcon-Riquelme, Marta E., Carmona-Saez, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065841/ https://www.ncbi.nlm.nih.gov/pubmed/33915751 http://dx.doi.org/10.3390/life11040299 |
Ejemplares similares
-
Scoring personalized molecular portraits identify Systemic Lupus Erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression
por: Toro-Domínguez, Daniel, et al.
Publicado: (2022) -
MetaGenyo: a web tool for meta-analysis of genetic association studies
por: Martorell-Marugan, Jordi, et al.
Publicado: (2017) -
Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren’s syndrome uncovered through gene expression meta-analysis
por: Toro-Domínguez, Daniel, et al.
Publicado: (2014) -
Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus Stratification
por: Toro-Domínguez, Daniel, et al.
Publicado: (2019) -
Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis
por: Toro-Domínguez, Daniel, et al.
Publicado: (2017)